No.1
Disclosure
2026/10/29 15:30
2027年3月期 第2四半期（中間期）決算短信〔IFRS〕（連結）
4502 Takeda Pharmaceutical武田薬品工業TSE Prime / Pharmaceuticals
1 post
Takeda Pharmaceutical (4502) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
Takeda Pharmaceutical (4502) Stock Price History
Takeda Pharmaceutical closed at ¥6,673 on Nov 11, 2026, +14.2% over 1 month, +57.9% over 1 year.
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥6,888Nov 5
1-Month Low¥5,889Oct 14
1-Week Change+1.3%vs Nov 4
1-Month Change+14.2%vs Oct 9
If you had invested ¥100,000 1 month ago, it would be worth ¥111,907 today (+11.9%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −9.6%, while this stock moved +11.9%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 11 (Wed) | ¥6,673 | +80 | +1.21% |
| Nov 10 (Tue) | ¥6,593 | −80 | −1.20% |
| Nov 9 (Mon) | ¥6,673 | +113 | +1.72% |
| Nov 6 (Fri) | ¥6,560 | −328 | −4.76% |
| Nov 5 (Thu) | ¥6,888 | +300 | +4.55% |
| Nov 4 (Wed) | ¥6,588 | −59 | −0.89% |
| Nov 2 (Mon) | ¥6,647 | −4 | −0.06% |
| Oct 30 (Fri) | ¥6,651 | +180 | +2.78% |
| Oct 29 (Thu) | ¥6,471 | +164 | +2.60% |
| Oct 28 (Wed) | ¥6,307 | −100 | −1.56% |
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥6,888Nov 5
3-Month Low¥5,513Aug 17
1-Month Change+14.2%vs Oct 9
3-Month Change+19.5%vs Aug 10
If you had invested ¥100,000 3 months ago, it would be worth ¥119,975 today (+20.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −9.3%, while this stock moved +20.0%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 11 (Wed) | ¥6,673 | +80 | +1.21% |
| Nov 10 (Tue) | ¥6,593 | −80 | −1.20% |
| Nov 9 (Mon) | ¥6,673 | +113 | +1.72% |
| Nov 6 (Fri) | ¥6,560 | −328 | −4.76% |
| Nov 5 (Thu) | ¥6,888 | +300 | +4.55% |
| Nov 4 (Wed) | ¥6,588 | −59 | −0.89% |
| Nov 2 (Mon) | ¥6,647 | −4 | −0.06% |
| Oct 30 (Fri) | ¥6,651 | +180 | +2.78% |
| Oct 29 (Thu) | ¥6,471 | +164 | +2.60% |
| Oct 28 (Wed) | ¥6,307 | −100 | −1.56% |
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥6,888Nov 5
6-Month Low¥4,748Jun 3
3-Month Change+19.5%vs Aug 10
6-Month Change+29.3%vs May 11
If you had invested ¥100,000 6 months ago, it would be worth ¥129,272 today (+29.3%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −1.9%, while this stock moved +29.3%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥6,673 | +0.3% |
| Oct 2026 | ¥6,651 | +15.1% |
| Sep 2026 | ¥5,780 | +0.3% |
| Aug 2026 | ¥5,765 | +4.6% |
| Jul 2026 | ¥5,513 | +6.9% |
| Jun 2026 | ¥5,155 | +0.7% |
| May 2026 | ¥5,118 | −2.9% |
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥6,888Nov 5
52-Week Low¥4,225Nov 11
Year to Date+38.0%vs Dec 30
From 52-Week High−3.1%Nov 5
If you had invested ¥100,000 1 year ago, it would be worth ¥157,941 today (+57.9%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +20.5%, while this stock moved +57.9%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥6,673 | +0.3% |
| Oct 2026 | ¥6,651 | +15.1% |
| Sep 2026 | ¥5,780 | +0.3% |
| Aug 2026 | ¥5,765 | +4.6% |
| Jul 2026 | ¥5,513 | +6.9% |
| Jun 2026 | ¥5,155 | +0.7% |
| May 2026 | ¥5,118 | −2.9% |
| Apr 2026 | ¥5,270 | −7.0% |
| Mar 2026 | ¥5,664 | −2.7% |
| Feb 2026 | ¥5,819 | +11.0% |
| Jan 2026 | ¥5,242 | +8.4% |
| Dec 2025 | ¥4,835 | +7.3% |
| Nov 2025 | ¥4,506 | ― |
Price13-week MA26-week MANikkei 225
3-Year High¥6,673Nov 11, 2026
3-Year Low¥3,933Apr 7, 2025
Annualized Return+16.6%
Max Drawdown−15.7%
If you had invested ¥100,000 3 years ago, it would be worth ¥158,316 today (+58.3%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +82.4%, while this stock moved +58.3%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥6,673 | +38.0% |
| 2025 | ¥4,835 | ― |
Price13-week MA26-week MANikkei 225
5-Year High¥6,673Nov 11, 2026
5-Year Low¥3,070Nov 29, 2021
Annualized Return+15.7%
Max Drawdown−19.1%
If you had invested ¥100,000 5 years ago, it would be worth ¥206,786 today (+106.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +105.9%, while this stock moved +106.8%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥6,673 | +38.0% |
| 2025 | ¥4,835 | ― |
Price1-year MA2-year MANikkei 225
All-Time High¥8,170Dec 2006
All-Time Low¥3,031Nov 2021
Total Change+7.6%vs Feb 2000
Annualized Return+0.3%
If you had invested ¥100,000 in Feb 2000, it would be worth ¥107,629 today (+7.6%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +201.2%, while this stock moved +7.6%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥6,673 | +38.0% |
| 2025 | ¥4,835 | +15.6% |
| 2024 | ¥4,181 | +3.1% |
| 2023 | ¥4,054 | −1.4% |
| 2022 | ¥4,111 | +31.0% |
| 2021 | ¥3,137 | −16.5% |
| 2020 | ¥3,755 | −13.3% |
| 2019 | ¥4,332 | +16.9% |
| 2018 | ¥3,705 | −42.1% |
| 2017 | ¥6,401 | +32.4% |
| 2016 | ¥4,835 | −20.3% |
| 2015 | ¥6,065 | +21.4% |
| 2014 | ¥4,997 | +3.6% |
| 2013 | ¥4,825 | +25.2% |
| 2012 | ¥3,855 | +14.1% |
| 2011 | ¥3,380 | −15.4% |
| 2010 | ¥3,995 | +4.3% |
| 2009 | ¥3,830 | −17.5% |
| 2008 | ¥4,640 | −29.4% |
| 2007 | ¥6,570 | −19.6% |
| 2006 | ¥8,170 | +28.1% |
| 2005 | ¥6,380 | +23.6% |
| 2004 | ¥5,160 | +21.4% |
| 2003 | ¥4,250 | −14.3% |
| 2002 | ¥4,960 | −16.4% |
| 2001 | ¥5,930 | −12.3% |
| 2000 | ¥6,760 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Feb 2000). Please check the latest prices before trading.
Takeda Pharmaceutical (4502) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of Takeda Pharmaceutical (4502)
Business overview
The group of 165 companies, including 154 consolidated subsidiaries and 10 equity-method affiliates and others, researches, develops and manufactures a wide range of pharmaceuticals and sells them worldwide. As a global R&D-driven biopharmaceutical company, it aims to create innovative medicines in its focus areas of gastrointestinal and inflammation, neuroscience and oncology, and also concentrates on plasma-derived therapies and vaccines. In Japan the company itself handles research and development, manufacturing and sales, while subsidiaries in each country do so in the US, Europe and Canada, China and elsewhere.
Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| Dividend yield | 3.06% | No. 17 in the sector (highest first); median 3.02% |
|---|---|---|
| PER | 50.8x | Above the sector median of 15.8x (No. 32 from the lowest) |
| PBR | 1.44x | Below the sector median of 1.84x (No. 27 from the lowest) |
| ROE | 2.83% | No. 31 in the sector (highest first); median 4.17% |
| Market cap | ¥10.7 tn | No. 2 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥6,888 | 11/5 |
|---|---|---|
| 52-week low | ¥4,225 | 2025/11/11 |
| Current position | 91.9% | Where the low is 0% and the high is 100% (close on 11/11: ¥6,673) |
| Year to date | +38.0% | No. 5 of 77 in the sector (best first) |
| 1 year | +57.9% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 gainers | 1 times | Latest: 10/15 (No. 33) |
|---|
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/11 17:30 JST. Updated every business day in the evening.
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.